Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
less decrease » teer decrease (Expand Search), we decrease (Expand Search), levels decreased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
less decrease » teer decrease (Expand Search), we decrease (Expand Search), levels decreased (Expand Search)
-
2361
-
2362
-
2363
-
2364
RICTOR silencing inhibits cell proliferation via UGCG regulation.
Published 2025“…(<b>C</b>) Cell proliferation studies show a decrease in the proliferation of MCF-7_RICTOR<sup>SH</sup> cells (mean ± SEM, <i>n</i> = 4) compared to MCF-7_SCRAM<sup>SH</sup> cells. …”
-
2365
Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration.
Published 2024“…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”
-
2366
-
2367
S1 File -
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2368
Confusion matrix for ClinicalBERT model.
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2369
Confusion matrix for LastBERT model.
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2370
Student model architecture.
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2371
Configuration of the LastBERT model.
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2372
Confusion matrix for DistilBERT model.
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2373
ROC curve for LastBERT model.
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2374
Sample Posts from the ADHD dataset.
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2375
Top-level overview for ADHD classification study.
Published 2025“…Furthermore underlined by the considerable decrease in model size without appreciable performance loss is the lower computational resources needed for training and deployment, hence facilitating greater applicability. …”
-
2376
Effects and Potential Risks of Chiral Penflufen on Pickled Cowpea: Combined Microbiome and Metabolomics
Published 2025“…<i>Rac</i>-penflufen treatment significantly decreased the relative abundance of <i>Lactiplantibacillus</i> while increasing <i>Weissella</i>, but the opposite effects were found in <i>R</i>- and <i>S</i>-penflufen treatments. …”
-
2377
-
2378
Related to Fig 3.
Published 2025“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX<sup>OE</sup> (mean ± SEM, <i>n</i> = 5) than BT-474_VECT<sup>OE</sup> tumors. …”
-
2379
-
2380